Biostimulants World Congress 2025 in Barcelona: market insights and emerging trends
Last week, the DAMAGRO team attended the Biostimulants World Congress in Barcelona. With our own stand and strong representation from both R&D and business development, the event offered an excellent opportunity to connect with new contacts, engage with partners and peers, and gain a clear view of the key dynamics shaping the biostimulants sector.
While our R&D colleagues focused on the latest scientific developments, the commercial team primarily attended market-oriented and strategic sessions. One presentation stood out in particular: “Market Trends & Insights: A Global Market Analysis” by Dunham Trimmer.
A market in sustained growth
The global biostimulants market continues to expand year after year. Within this broad category, non-microbial biostimulants are showing particularly strong momentum.
For this segment, a compound annual growth rate (CAGR) of 9.93% is projected between 2024 and 2030 — a clear indication that demand for high-quality, well-substantiated biostimulant solutions continues to rise.
For DAMAGRO, active in protein hydrolysates, this represents a highly relevant and encouraging trend.
Shifting regional dynamics
The analysis also highlighted notable regional differences:
The United States remains the largest biostimulants market worldwide.
Brazil is among the fastest-growing markets.
Europe continues to be the historical leader and first mover, driven by innovation, product development and a strong regulatory framework.
At the same time, Europe’s position is increasingly challenged by emerging players that can scale more rapidly or operate under less stringent regulatory conditions. Regulation therefore remains a defining factor in the European market. At DAMAGRO, we closely monitor these developments — both internally and through industry organisations — to ensure our activities remain compliant, robust and future-proof.
Strong growth, intense competition
One of the most striking insights was the contrast between the large number of market participants and the high concentration of market share:
25% of the market is held by 4 companies
50% by 19 companies
75% by 80 companies
alongside more than 650 active companies worldwide
This underlines that the biostimulants market is not only fast-growing, but also highly competitive. In such an environment, clear positioning, solid scientific validation and genuine differentiation are more important than ever.
Looking ahead
Amino acids and hydrolysates remain a key product category, but the market is clearly moving towards:
clearer and more stringent regulation
more specialised solutions
higher expectations in terms of proof of efficacy and performance
At DAMAGRO, we are acutely aware of these shifts. They play a central role in shaping our strategic direction — from product development to market positioning.
The Biostimulants World Congress therefore delivered valuable insights, which we actively integrate into our ongoing growth strategy and long-term vision for the sector.
